Manganese neurotoxicity: a review of clinical features, imaging and pathology

Neurotoxicology. 1999 Apr-Jun;20(2-3):227-38.

Abstract

Manganese intoxication can result in a syndrome of parkinsonism and dystonia. If these extrapyramidal findings are present, they are likely to be irreversible and even progress after termination of the exposure to manganese. Clinical features are usually sufficient to distinguish these patients from those with Parkinson's disease. The neurological syndrome does not respond to levodopa. Imaging of the brain may reveal MRI signal changes in the globus pallidus, striatum, and midbrain. Positron emission tomography reveals normal presynaptic and postsynaptic nigrostriatal dopaminergic function. The primary site of neurological damage has been shown by pathological studies to be the globus pallidus. The mechanism of toxicity is not clear.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Clinical Trials as Topic
  • Diagnosis, Differential
  • Globus Pallidus / drug effects*
  • Humans
  • Magnetic Resonance Imaging
  • Manganese Poisoning*
  • Nervous System Diseases / chemically induced*
  • Nervous System Diseases / diagnosis*
  • Nervous System Diseases / drug therapy
  • Parkinson Disease / diagnosis*
  • Tomography, Emission-Computed